2BB score and signals
BioXcel Therapeutics, Inc.’s current 2BB score is 14 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 60 | Strong |
| Risk | 59 | Moderate |
Company facts
| Headquarters | New Haven, Connecticut, United States |
| Founded | 2017 |
| Employees | 29 |
| 52-week range | $0.74 – $6.85 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.6528 | — | $268,596.00 |
| 2026-08-10 | — | -0.5236 | — | $261,803.00 |
| 2026-05-15 | -0.54 | -0.4947 | $206,000.00 | $356,235.00 |
| 2026-03-27 | -0.58 | -0.765 | $256,000.00 | $165,240.00 |
Related companies
2BBBullish & Bearish